Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> A >> (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide

(2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide
[CAS# 370094-12-5]

List of Suppliers
CAS: 370094-12-5
Product: (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide
No suppilers available.
Identification
Name (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide
Molecular Structure CAS # 370094-12-5, (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide
Molecular Formula C22H26N2O5S
Molecular Weight 430.52
CAS Registry Number 370094-12-5
EC Number 641-705-9
Properties
Solubility Very slightly soluble (0.47 g/L) (25 ºC), Calc.*
Density 1.32±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Market Analysis Reports
List of Reports Available for (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide
Related Products
(2S,3S)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one  (2S-cis)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-5-[2-(methylamino)ethyl]-1,5-benzothiazepin-4(5H)-one monohydrochloride  5-(Acetyloxy)-4,5-dihydro-2-methyl-3-furancarboxylic acid methyl ester  4-(Acetyloxy)-3,4-dihydro-1(2H)-naphthalenone  (2R,3S,6S)-3-(Acetyloxy)-3,6-dihydro-6-[2-(trimethylsilyl)ethynyl]-2H-pyran-2-methanol 2-acetate  (6beta,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione  12-(Acetyloxy)-3,6-dihydroxy-7-oxocholan-24-oic acid methyl ester  (3alpha,5beta)-3-(Acetyloxy)-17,21-dihydroxy-pregnane-11,20-dione  3-[4-(Acetyloxy)-3,5-dimethoxycinnamic acid  (2R-trans)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride  (11alpha)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione  6-[(3R,4R)-3-(Acetyloxy)-N,4-dimethyl-6-oxo-L-norleucine]-cyclosporin A  1-Acetyloxy-2,5-dioxopyrrolidine-3-sulfonic acid  (3beta,5beta,15beta,16beta)-16-(Acetyloxy)-14,15-epoxy-3,5-dihydroxy-19-oxobufa-20,22-dienolide  (3alpha,7alpha)-3-(Acetyl-d3-oxy)-12,13-epoxy-7,15-dihydroxytrichothec-9-en-8-one  N-[7-[[2-(Acetyloxy)ethoxy]methyl]-6,7-dihydro-6-oxo-1H-purin-2-yl]acetamide  (1Z)-1-[5-(Acetyloxy)-3-ethyl-2(3H)-benzothiazolylidene]-2-propanone  (4S)-4-(Acetyloxy)-4-ethyl-9-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione  5-[2-(Acetyloxy)ethyl]-4-methyl-3-thiophenecarboxylic acid ethyl ester  (4S)-3-[(5S)-5-(Acetyloxy)-5-(4-fluorophenyl)-1-oxopentyl]-4-phenyl-2-oxazolidinone